SS

Sohan Singh

Active Director Director DIN 10935240
DIN 10935240 First appointment Jan 2025 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sohan Singh

Data last updated:

Sohan Singh is a Director at Cure Catalyst Clinical Research Private Limited (since 2025). The company operates in Professional Services.

DIN 10935240
Primary Designation Director
Industry Professional Services
First Appointment 31 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Jan 20252025Active

Board colleagues of Sohan Singh

NameDINCompanyDesignation
Vishwas Saxena10935239Cure Catalyst Clinical Research Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cure Catalyst Clinical Research Private Limited
Premium access

Shareholding and investment profile for Sohan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sohan Singh

Sohan Singh currently holds 1 directorship: Cure Catalyst Clinical Research Private Limited (Director, since 31 Jan 2025).

Sohan Singh was first appointed on 31 Jan 2025 as Director at Cure Catalyst Clinical Research Private Limited.

The current boards of Sohan Singh's companies include Vishwas Saxena (Cure Catalyst Clinical Research Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available